Difficulty: Medium
Average Score: 89%
Practice
Fibrinolysis is mainly carried out by
Correct answer
C
Rationale
Fibrinolysis is a critical process in the body that helps dissolve blood clots. In this context, the correct answer is C) Both (a) and (b) - Tissue-type plasminogen activator (t-PA) and Urokinase-type plasminogen activator (u-PA).
Tissue-type plasminogen activator (t-PA) is primarily produced by endothelial cells and plays a crucial role in converting plasminogen to plasmin, which then degrades fibrin clots. Urokinase-type plasminogen activator (u-PA) is another enzyme that also converts plasminogen to plasmin, contributing to the fibrinolytic process.
Option A) Tissue-type plasminogen activator (t-PA) is correct because it is a key activator in fibrinolysis. Option B) Urokinase-type plasminogen activator (u-PA) is also correct as it is another important activator in the breakdown of blood clots. Therefore, the correct answer C) Both (a) and (b) encompasses the main activators involved in fibrinolysis.
Option D) None of the above is incorrect as both t-PA and u-PA are essential components of the fibrinolytic system.
Understanding the mechanisms of fibrinolysis is crucial in the context of cardiovascular drugs pharmacology, as drugs targeting these pathways are used in clinical practice to manage conditions such as acute myocardial infarction and ischemic stroke. Knowing the specific activators involved in fibrinolysis helps healthcare professionals make informed decisions regarding treatment options for patients with thrombotic disorders.
Tissue-type plasminogen activator (t-PA) is primarily produced by endothelial cells and plays a crucial role in converting plasminogen to plasmin, which then degrades fibrin clots. Urokinase-type plasminogen activator (u-PA) is another enzyme that also converts plasminogen to plasmin, contributing to the fibrinolytic process.
Option A) Tissue-type plasminogen activator (t-PA) is correct because it is a key activator in fibrinolysis. Option B) Urokinase-type plasminogen activator (u-PA) is also correct as it is another important activator in the breakdown of blood clots. Therefore, the correct answer C) Both (a) and (b) encompasses the main activators involved in fibrinolysis.
Option D) None of the above is incorrect as both t-PA and u-PA are essential components of the fibrinolytic system.
Understanding the mechanisms of fibrinolysis is crucial in the context of cardiovascular drugs pharmacology, as drugs targeting these pathways are used in clinical practice to manage conditions such as acute myocardial infarction and ischemic stroke. Knowing the specific activators involved in fibrinolysis helps healthcare professionals make informed decisions regarding treatment options for patients with thrombotic disorders.